Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$125.15
+1.6%
$119.76
$96.43
$153.84
$35.50B1.241.94 million shs381,957 shs
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$132.68
-0.8%
$130.41
$110.86
$141.23
$230.97B0.696.64 million shs601,017 shs
RH stock logo
RH
RH
$220.44
+1.3%
$218.37
$123.03
$457.26
$4.13B2.151.31 million shs283,368 shs
Roche Holding AG stock logo
RHHBY
Roche
$40.92
-1.0%
$40.33
$34.10
$44.31
$260.38B0.472.22 million shs279,901 shs
Roche Holding AG stock logo
RHHVF
Roche
$328.62
-0.6%
$322.92
$269.80
$354.19
N/AN/A8,632 shs152 shs
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$475.61
-0.7%
$466.86
$385.46
$623.77
$179.78B0.752.39 million shs279,277 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.00%-4.27%+3.26%+3.46%-10.28%
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%+0.76%+1.72%-0.05%+15.05%
RH stock logo
RH
RH
0.00%-12.89%-6.62%+15.22%-32.07%
Roche Holding AG stock logo
RHHBY
Roche
0.00%-3.84%+4.47%+2.96%+5.73%
Roche Holding AG stock logo
RHHVF
Roche
0.00%-3.92%+3.28%+2.65%+7.17%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.00%-2.58%-2.14%+18.35%-21.55%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$125.15
+1.6%
$119.76
$96.43
$153.84
$35.50B1.241.94 million shs381,957 shs
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$132.68
-0.8%
$130.41
$110.86
$141.23
$230.97B0.696.64 million shs601,017 shs
RH stock logo
RH
RH
$220.44
+1.3%
$218.37
$123.03
$457.26
$4.13B2.151.31 million shs283,368 shs
Roche Holding AG stock logo
RHHBY
Roche
$40.92
-1.0%
$40.33
$34.10
$44.31
$260.38B0.472.22 million shs279,901 shs
Roche Holding AG stock logo
RHHVF
Roche
$328.62
-0.6%
$322.92
$269.80
$354.19
N/AN/A8,632 shs152 shs
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$475.61
-0.7%
$466.86
$385.46
$623.77
$179.78B0.752.39 million shs279,277 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.00%-4.27%+3.26%+3.46%-10.28%
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%+0.76%+1.72%-0.05%+15.05%
RH stock logo
RH
RH
0.00%-12.89%-6.62%+15.22%-32.07%
Roche Holding AG stock logo
RHHBY
Roche
0.00%-3.84%+4.47%+2.96%+5.73%
Roche Holding AG stock logo
RHHVF
Roche
0.00%-3.92%+3.28%+2.65%+7.17%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.00%-2.58%-2.14%+18.35%-21.55%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
2.50
Moderate Buy$140.0811.93% Upside
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.91
Moderate Buy$144.478.89% Upside
RH stock logo
RH
RH
2.35
Hold$259.2917.63% Upside
Roche Holding AG stock logo
RHHBY
Roche
2.80
Moderate BuyN/AN/A
Roche Holding AG stock logo
RHHVF
Roche
0.00
N/AN/AN/A
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
2.77
Moderate Buy$592.2424.52% Upside

Current Analyst Ratings Breakdown

Latest A, ABT, RH, RHHBY, RHHVF, and TMO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/15/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$140.00 ➝ $150.00
9/12/2025
RH stock logo
RH
RH
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$390.00 ➝ $320.00
9/12/2025
RH stock logo
RH
RH
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$235.00 ➝ $265.00
9/12/2025
RH stock logo
RH
RH
Guggenheim
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$300.00
9/12/2025
RH stock logo
RH
RH
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$436.00 ➝ $385.00
9/12/2025
RH stock logo
RH
RH
Telsey Advisory Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOutperformHold$220.00
9/11/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeEqual WeightOverweight$490.00 ➝ $550.00
9/8/2025
RH stock logo
RH
RH
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$275.00 ➝ $295.00
9/8/2025
RH stock logo
RH
RH
Telsey Advisory Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperformMarket Perform$255.00 ➝ $220.00
9/3/2025
RH stock logo
RH
RH
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$200.00 ➝ $233.00
9/2/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetOutperform$561.00
(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$6.51B5.45$6.35 per share19.72$20.53 per share6.10
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$41.95B5.50$6.53 per share20.31$27.62 per share4.80
RH stock logo
RH
RH
$3.18B1.30$18.17 per share12.13($8.79) per share-25.08
Roche Holding AG stock logo
RHHBY
Roche
$68.73B3.79$3.27 per share12.52$6.46 per share6.33
Roche Holding AG stock logo
RHHVF
Roche
N/AN/AN/AN/AN/AN/A
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$43.21B4.16$29.80 per share15.96$129.54 per share3.67
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.29B$4.2629.4020.583.8317.97%25.51%12.94%11/24/2025 (Estimated)
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$13.40B$7.9816.6323.152.5432.43%18.32%10.71%10/15/2025 (Estimated)
RH stock logo
RH
RH
$72.41M$5.3740.9815.992.093.20%-113.58%3.08%N/A
Roche Holding AG stock logo
RHHBY
Roche
$9.40BN/A0.0013.642.28N/AN/AN/AN/A
Roche Holding AG stock logo
RHHVF
Roche
N/A$10.8130.40N/AN/AN/AN/AN/A
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$6.34B$17.2927.5418.612.5615.24%16.82%8.38%10/22/2025 (Estimated)

Latest A, ABT, RH, RHHBY, RHHVF, and TMO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/11/2025Q2 2026
RH stock logo
RH
RH
$3.22$2.93-$0.29$2.62$906.58 million$899.15 million
8/27/2025Q3 2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.37$1.37N/A$1.18$1.67 billion$1.74 billion
7/23/2025Q2 2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$5.22$5.36+$0.14$4.28$10.68 billion$10.86 billion
7/17/2025Q2 2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.26$1.26N/A$1.01$11.01 billion$11.14 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$0.990.79%N/A23.24%9 Years
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.361.78%N/A29.57%54 Years
RH stock logo
RH
RH
N/AN/AN/AN/AN/A
Roche Holding AG stock logo
RHHBY
Roche
$0.872.13%N/AN/AN/A
Roche Holding AG stock logo
RHHVF
Roche
$7.802.37%N/A72.16%N/A
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$1.720.36%N/A9.95%8 Years

Latest A, ABT, RH, RHHBY, RHHVF, and TMO Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/10/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
quarterly$0.430.36%9/15/20259/15/202510/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.53
2.25
1.71
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.25
1.82
1.30
RH stock logo
RH
RH
N/A
1.26
0.26
Roche Holding AG stock logo
RHHBY
Roche
0.85
1.48
1.20
Roche Holding AG stock logo
RHHVF
Roche
N/AN/AN/A
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.65
1.93
1.50

Institutional Ownership

CompanyInstitutional Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
RH stock logo
RH
RH
90.17%
Roche Holding AG stock logo
RHHBY
Roche
N/A
Roche Holding AG stock logo
RHHVF
Roche
29.01%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
89.23%

Insider Ownership

CompanyInsider Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
RH stock logo
RH
RH
27.00%
Roche Holding AG stock logo
RHHBY
Roche
N/A
Roche Holding AG stock logo
RHHVF
Roche
N/A
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.33%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
17,900283.50 millionN/AOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.74 billion1.73 billionOptionable
RH stock logo
RH
RH
6,34018.75 million13.68 millionOptionable
Roche Holding AG stock logo
RHHBY
Roche
103,2496.36 billionN/ANot Optionable
Roche Holding AG stock logo
RHHVF
Roche
103,605N/AN/ANot Optionable
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
125,000377.61 million376.37 millionOptionable

Recent News About These Companies

Thermo Fisher Scientific Inc. $TMO Shares Acquired by Swedbank AB
Zacks Research Issues Pessimistic Outlook for TMO Earnings

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Agilent Technologies stock logo

Agilent Technologies NYSE:A

$125.15 +1.91 (+1.55%)
As of 11:25 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$132.68 -1.05 (-0.79%)
As of 11:25 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

RH stock logo

RH NYSE:RH

$220.44 +2.82 (+1.30%)
As of 11:25 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

RH, together with its subsidiaries, operates as a retailer in the home furnishings market. The company offers products in various categories, including furniture, lighting, textiles, bathware, décor, outdoor and garden, baby, child, and teen furnishings. It provides its products through rh.com, rhbabyandchild.com, rhteen.com, rhmodern.com, and waterworks.com online channels, as well as operates RH Galleries, RH outlet stores, RH Guesthouse, and Waterworks showrooms in the United States, Canada, the United Kingdom, and Germany. The company was formerly known as Restoration Hardware Holdings, Inc. and changed its name to RH in January 2017. RH was incorporated in 2011 and is headquartered in Corte Madera, California.

Roche stock logo

Roche OTCMKTS:RHHBY

$40.92 -0.43 (-1.04%)
As of 11:04 AM Eastern

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Roche stock logo

Roche OTCMKTS:RHHVF

$328.62 -1.90 (-0.57%)
As of 11:01 AM Eastern

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Thermo Fisher Scientific stock logo

Thermo Fisher Scientific NYSE:TMO

$475.61 -3.42 (-0.71%)
As of 11:25 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.